Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

Laura Guay(Johns Hopkins University), J. Brooks Jackson(VA Tennessee Valley Healthcare System), Joseph Sherman(Johns Hopkins University), Kevin Dransfield(Boehringer Ingelheim (United States)), Paul M. Bakaki(University of Washington), Melissa Allen(Family Health International 360), Lynda Emel(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Philippa Musoke(Centers for Disease Control and Prevention), Francis Mmiro(Makerere University), Danstan Bagenda(Makerere University), Martina Deseyve(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Thomas R. Fleming(University of Washington), Mary Glenn Fowler(Johns Hopkins University), Dorothy Bray(Wellcome Library), Clemensia Nakabiito(Makerere University), Mark Mirochnick(Boston University), Paolo Miotti(Office of AIDS Research), Constance Ducar(Fred Hutch Cancer Center)
The Lancet
September 1, 1999
Cited by 1,654


Related Papers